380 related articles for article (PubMed ID: 34813676)
1. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
3. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
4. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
5. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
[TBL] [Abstract][Full Text] [Related]
6. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
[TBL] [Abstract][Full Text] [Related]
7. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
8. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
9. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
Zhang L; Luo X; Qiao S
Br J Cancer; 2022 Jul; 127(1):30-42. PubMed ID: 35249103
[TBL] [Abstract][Full Text] [Related]
10. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
Qi L; Yin Y; Sun M
Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
Wen S; Wei Y; Zen C; Xiong W; Niu Y; Zhao Y
Mol Cancer; 2020 Dec; 19(1):171. PubMed ID: 33308223
[TBL] [Abstract][Full Text] [Related]
12. Exercise Mitigates Endothelial Pyroptosis and Atherosclerosis by Downregulating NEAT1 Through N6-Methyladenosine Modifications.
Yang Q; Chen S; Wang X; Yang X; Chen L; Huang T; Zheng Y; Zheng X; Wu X; Sun Y; Wu J
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):910-926. PubMed ID: 37078289
[TBL] [Abstract][Full Text] [Related]
13. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
14. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
Hu N; Ji H
Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
[TBL] [Abstract][Full Text] [Related]
16. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
17. Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.
Yin L; Ma C; Hou S; Ma X
Bioengineered; 2022 Mar; 13(3):4773-4785. PubMed ID: 35139773
[TBL] [Abstract][Full Text] [Related]
18. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
[TBL] [Abstract][Full Text] [Related]
20. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
